Skip to main content
Standard Chemical & Pharmaceutical Co., Ltd. logo

Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,588 across all filing types
Latest filing 2026-04-10 AGM Information
Country TW Taiwan
Listing TW 1720

About Standard Chemical & Pharmaceutical Co., Ltd.

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
115年年報及股東會資料 — 2026_1720_20260512F02.pdf
AGM Information Classification · 91% confidence The document is the “115年股東常會議事手冊” (Annual General Meeting handbook) containing the AGM procedures, agenda, reports (business report, audit report, dividend/distribution proposals), discussion items, and attachments (financial statements, charter amendments, etc.). It is not the standalone Annual Report or financial statements themselves, but the presentation/materials prepared for the shareholders’ meeting. Therefore it is classified as AGM Information (AGM-R).
2026-04-10 Chinese
115年年報及股東會資料 — 2026_1720_20260512F13.pdf
AGM Information Classification · 92% confidence The document is titled “115年股東常會議案參考資料” and contains the list of proposals and reference materials for the company’s Annual General Meeting (approving the 114年度營業報告書及財務報表, earnings distribution, capital increase, amendments to the Articles, etc.). It is clearly AGM meeting materials rather than an earnings release, annual report, or simple announcement. Therefore it matches the AGM Information category (AGM-R).
2026-04-10 Chinese
115年年報及股東會資料 — 2026_1720_20260512FE1.pdf
Proxy Solicitation & Information Statement Classification · 87% confidence The document is a formal notice convening the 2026 Annual Shareholders’ Meeting, detailing the agenda items, proposals for ratification and discussion, dividend distribution proposals, and instructions for attendance or proxy voting. It is sent to shareholders to inform them of meeting details and solicit votes. This matches the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-10 English
115年03月內部人持股異動(事後)
Director's Dealing Classification · 87% confidence The document is a Taiwan public information disclosure from a listed company (“生達”), detailing insider shareholdings (directors, chairman, general manager, spouses, minor children) with columns showing beginning balances, monthly increases and decreases, and ending balances. This table format matches insider personal share transactions and holdings disclosures rather than company financial results or general report announcements. Therefore, it fits the “Director’s Dealing” category (code DIRS).
2026-04-10 Chinese
115年03月董事會成員及持股
Director's Dealing Classification · 90% confidence The document is a statutory monthly disclosure (“內部人持股異動事後申報表”) of insider shareholdings and pledged shares for directors, supervisors and senior management. It does not present an earnings or financial report but specifically lists personal shareholdings by insiders. This falls under ‘Director’s Dealing’ (insider holdings/transactions) rather than major‐shareholder threshold notifications or any other financial report category.
2026-04-10 Chinese
115年03月內部人持股異動(事後)
Director's Dealing Classification · 88% confidence The document is a public disclosure of shareholdings by company insiders (directors, chairman, independent directors, management, major shareholders, etc.), listing their share counts and changes during the month. This fits the definition of a Director’s Dealing report – insider share transactions and holdings disclosures. It is not a full financial report, earnings release, or announcement but a detailed insider trading/holding disclosure form.
2026-04-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.